85 related articles for article (PubMed ID: 26281861)
1. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
[TBL] [Abstract][Full Text] [Related]
2. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
3. CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort.
Grass JK; Grupp K; Kluth M; Hube-Magg C; Simon R; Kemper M; Izbicki JR; Sauter G; Melling N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672555
[TBL] [Abstract][Full Text] [Related]
4. Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
Li P; Xiao ZT; Braciak TA; Ou QJ; Chen G; Oduncu FS
Oncol Res Treat; 2016; 39(11):696-702. PubMed ID: 27855388
[TBL] [Abstract][Full Text] [Related]
5. Strategies for developing Ki67 as a useful biomarker in breast cancer.
Denkert C; Budczies J; von Minckwitz G; Wienert S; Loibl S; Klauschen F
Breast; 2015 Nov; 24 Suppl 2():S67-72. PubMed ID: 26283598
[TBL] [Abstract][Full Text] [Related]
6. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.
Reitsam NG; Grosser B; Enke JS; Mueller W; Westwood A; West NP; Quirke P; Märkl B; Grabsch HI
Transl Oncol; 2024 Jun; 44():101913. PubMed ID: 38593584
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach.
Razmi M; Tajik F; Hashemi F; Yazdanpanah A; Hashemi-Niasari F; Divsalar A
J Gastrointest Cancer; 2024 Feb; ():. PubMed ID: 38411875
[TBL] [Abstract][Full Text] [Related]
8. Exploration and validation of the Ki67, Her-2, and mutant P53 protein-based risk model, nomogram and lymph node metastasis model for predicting colorectal cancer progression and prognosis.
Yuan C; Huang J; Wang Y; Xiao H
Front Oncol; 2023; 13():1236441. PubMed ID: 38074671
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.
Kasprzak A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760539
[TBL] [Abstract][Full Text] [Related]
10. Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes.
Patel K; Bora V; Patel B
Cancer Chemother Pharmacol; 2024 Jan; 93(1):55-70. PubMed ID: 37755518
[TBL] [Abstract][Full Text] [Related]
11. Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tissue composition.
Yuan J; Liu K; Zhang Y; Yang Y; Xu H; Han G; Lyu H; Liu M; Tan W; Feng Z; Gong H; Zhan S
World J Surg Oncol; 2023 Sep; 21(1):306. PubMed ID: 37749564
[TBL] [Abstract][Full Text] [Related]
12. Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma.
Yuan Y; Ren W; Zhu J; Ji S; Yang Q
Ann Med; 2023; 55(2):2244181. PubMed ID: 37557892
[TBL] [Abstract][Full Text] [Related]
13. The use of quantitative T1-mapping to identify cells and collagen fibers in rectal cancer.
Yuan J; Wen Q; Wang H; Wang J; Liu K; Zhan S; Liu M; Gong Z; Tan W
Front Oncol; 2023; 13():1189334. PubMed ID: 37546428
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of 5-fluorouracil polymeric nanogel synthesized by gamma radiation on a rat model of colon carcinoma: a proposed mechanism.
Abo-Zaid OAR; Moawed FSM; Barakat WEM; Ghobashy MM; Ahmed ESA
Discov Oncol; 2023 Jul; 14(1):138. PubMed ID: 37493814
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor.
Chen D; Li Q; Yu H
Front Oncol; 2023; 13():1181522. PubMed ID: 37305574
[TBL] [Abstract][Full Text] [Related]
16. 10-Hydroxy Decanoic Acid-Based Vesicles as a Novel Topical Delivery System: Would It Be a Better Platform Than Conventional Oleic Acid Ufasomes for Skin Cancer Treatment?
Atef B; Ishak RAH; Badawy SS; Osman R
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242703
[TBL] [Abstract][Full Text] [Related]
17. Association between Ki67 expression and therapeutic outcome in colon cancer.
Liu Q; Ran D; Wang L; Feng J; Deng W; Mei D; Peng Y; Du C
Oncol Lett; 2023 Jun; 25(6):272. PubMed ID: 37216165
[TBL] [Abstract][Full Text] [Related]
18. Energy Metabolism Is Altered in Radioresistant Rectal Cancer.
Buckley CE; Yin X; Meltzer S; Ree AH; Redalen KR; Brennan L; O'Sullivan J; Lynam-Lennon N
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108244
[TBL] [Abstract][Full Text] [Related]
19. An iodide-containing covalent organic framework for enhanced radiotherapy.
Zhou LL; Guan Q; Zhou W; Kan JL; Dong YB
Chem Sci; 2023 Mar; 14(13):3642-3651. PubMed ID: 37006674
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers.
Melling N; Grass J; Reeh M; Tachezy M; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7579-7585. PubMed ID: 36976352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
